HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association between interleukin-10 gene rs1800896 polymorphism and diabetic retinopathy in a Chinese Han population.

Abstract
The levels of cytokines, inflammatory cells, and angiogenic factors increase following diabetic retinopathy (DR), and the association between interleukin-10 (IL-10) gene rs1800896 polymorphism (IL-10 -1082G/A polymorphism) and DR in different populations has been extensively studied. However, the findings are conflicting, and there is no relevant research in Chinese subjects. Therefore, this case-control study involving 327 cases (type 2 diabetes patients with proliferative DR (PDR)) and 461 controls (type 2 diabetes patients without DR) was conducted to address the relationship between IL-10 gene rs1800896 polymorphism and risk of PDR in Chinese population. Genotyping was performed using PCR-based restriction fragment length polymorphism (PCR-RFLP) assay. It was found that GG genotype or G allele of the IL-10 gene rs1800896 polymorphism was associated with decreased risk for PDR. In conclusion, IL-10 gene rs1800896 polymorphism decreases the risk of PDR.
AuthorsLun Liu, Jie Zheng, Yajing Xu, Jian Gao, Lingling Fan, Dong Xu
JournalBioscience reports (Biosci Rep) Vol. 39 Issue 4 (04 30 2019) ISSN: 1573-4935 [Electronic] England
PMID30890581 (Publication Type: Journal Article)
Copyright© 2019 The Author(s).
Chemical References
  • IL10 protein, human
  • Interleukin-10
Topics
  • Adult
  • Aged
  • Asian People (genetics)
  • Case-Control Studies
  • China (epidemiology)
  • Diabetes Mellitus, Type 2 (epidemiology, genetics)
  • Diabetic Retinopathy (epidemiology, genetics)
  • Female
  • Humans
  • Interleukin-10 (genetics)
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide
  • Protective Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: